Antigen composition for detecting Chagas disease

US10094828B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10094828-B2
Application numberUS-201715587842-A
CountryUS
Kind codeB2
Filing dateMay 5, 2017
Priority dateNov 6, 2014
Publication dateOct 9, 2018
Grant dateOct 9, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention concerns a composition of polypeptides suitable for detecting antibodies against Trypanosoma cruzi ( T. cruzi ) in an isolated biological sample consisting of three polypeptides 1F8, JL7 and Cruzipain. A method of producing a soluble and immunoreactive composition of polypeptides suitable for detecting antibodies against T. cruzi using said composition of polypeptides is also part of the invention. Moreover, the invention concerns a method for detecting antibodies specific for T. cruzi in an isolated sample wherein a composition of said T. cruzi polypeptides is used as well as a reagent kit comprising said composition of T. cruzi polypeptides.

First claim

Opening claim text (preview).

The invention claimed is: 1. A composition of polypeptides suitable for detecting antibodies agains Trypanosoma cruzi in an isolated biological sample, said composition comprising three recombinantly or synthetically produced polypeptides specific for Trypanosoma cruzi , wherein said polypeptides are selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2 and SEQ ID NO:3. 2. A composition of polypeptides according to claim 1 wherein said composition comprises calcium ions in a concentration of 0.1 to 10 millions per liter. 3. A reagent kit for the detection of anti- Trypanosoma cruzi antibodies, comprising a composition of Trypanosoma cruzi polypeptides according to claim 1 .

Assignees

Inventors

Classifications

  • Detection of antibodies in sample from host which are directed against antigens from microorganisms · CPC title

  • from protozoa · CPC title

  • Protozoa · CPC title

  • Trypanosoma antigens · CPC title

  • for pre-existing immune complex or autoimmune disease {, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10094828B2 cover?
The present invention concerns a composition of polypeptides suitable for detecting antibodies against Trypanosoma cruzi ( T. cruzi ) in an isolated biological sample consisting of three polypeptides 1F8, JL7 and Cruzipain. A method of producing a soluble and immunoreactive composition of polypeptides suitable for detecting antibodies against T. cruzi using said composition of polypeptides …
Who is the assignee on this patent?
Roche Diagnostics Operations Inc, Indiana Univ Research And Technology
What technology area does this patent fall under?
Primary CPC classification G01N33/56905. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Oct 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).